DECOUDREAUX ALECIA A
CIK 1233354 · View on SEC EDGAR ↗
Insider
First SEC filing: May 15, 2026 · Latest: May 15, 2026
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 24 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 14, 2026 | CVS | A | 1,448 | $97.15 | $140,673 | 42,182 Direct | +3.55% | Acquired | -3.7% (price as of 2026-08-21) |
| Nov. 20, 2025 | CVS | A | 1,652 | $76.04 | $125,618 | 40,054 Direct | +4.30% | Acquired | 23.1% (price as of 2026-08-21) |
| May 15, 2025 | CVS | A | 2,077 | $60.47 | $125,596 | 37,765 Direct | +5.82% | Acquired | 54.8% (price as of 2026-08-21) |
| Nov. 21, 2024 | CVS | A | 2,200 | $57.10 | $125,620 | 34,934 Direct | +6.72% | Acquired | 63.9% (price as of 2026-08-21) |
| May 16, 2024 | CVS | A | 2,184 | $57.52 | $125,624 | 31,994 Direct | +7.33% | Acquired | 62.7% (price as of 2026-08-21) |
| Nov. 15, 2023 | CVS | A | 1,817 | $69.13 | $125,609 | 29,200 Direct | +6.64% | Acquired | 35.4% (price as of 2026-08-21) |
| May 18, 2023 | CVS | A | 1,329 | $69.31 | $92,113 | 26,715 Direct | +5.24% | Acquired | 35.0% (price as of 2026-08-21) |
| Nov. 17, 2022 | CVS | A | 1,323 | $94.93 | $125,592 | 25,212 Direct | +5.54% | Acquired | -1.4% (price as of 2026-08-21) |
| May 11, 2022 | CVS | A | 1,282 | $97.99 | $125,623 | 23,489 Direct | +5.77% | Acquired | -4.5% (price as of 2026-08-21) |
| Nov. 17, 2021 | CVS | A | 1,254 | $92.73 | $116,283 | 22,052 Direct | +6.03% | Acquired | 0.9% (price as of 2026-08-21) |
| May 13, 2021 | CVS | A | 1,379 | $84.27 | $116,208 | 20,599 Direct | +7.17% | Acquired | 11.1% (price as of 2026-08-21) |
| Nov. 18, 2020 | CVS | A | 1,752 | $66.35 | $116,245 | 18,964 Direct | +10.18% | Acquired | 41.0% (price as of 2026-08-21) |
| May 14, 2020 | CVS | A | 1,866 | $62.31 | $116,270 | 16,933 Direct | +12.38% | Acquired | 50.2% (price as of 2026-08-21) |
| Nov. 20, 2019 | CVS | A | 1,552 | $74.92 | $116,276 | 14,832 Direct | +11.69% | Acquired | 24.9% (price as of 2026-08-21) |
| May 16, 2019 | CVS | A | 2,223 | $52.30 | $116,263 | 13,066 Direct | +20.50% | Acquired | 78.9% (price as of 2026-08-21) |
| Nov. 7, 2018 | CVS | A | 1,332 | $78.77 | $104,922 | 2,970 Direct | +81.32% | Acquired | 18.8% (price as of 2026-08-21) |
| June 4, 2018 | CVS | A | 1,638 | $64.10 | $104,996 | 1,638 Direct | — | Acquired | 46.0% (price as of 2026-08-21) |
| Nov. 8, 2017 | CVS | A | 2,029 | $68.99 | $139,981 | 10,363 Direct | +24.35% | Acquired | 35.7% (price as of 2026-08-21) |
| May 10, 2017 | CVS | A | 1,730 | $80.94 | $140,026 | 8,221 Direct | +26.65% | Acquired | 15.6% (price as of 2026-08-21) |
| Nov. 2, 2016 | CVS | A | 1,668 | $83.95 | $140,029 | 6,434 Direct | +35.00% | Acquired | 11.5% (price as of 2026-08-21) |
| May 19, 2016 | CVS | A | 1,387 | $100.95 | $140,018 | 4,696 Direct | +41.92% | Acquired | -7.3% (price as of 2026-08-21) |
| Nov. 4, 2015 | CVS | A | 1,406 | $99.57 | $139,995 | 3,280 Direct | +75.03% | Acquired | -6.0% (price as of 2026-08-21) |
| May 7, 2015 | CVS | A | 1,409 | $99.36 | $139,998 | 1,862 Direct | +311.04% | Acquired | -5.8% (price as of 2026-08-21) |
| March 5, 2015 | CVS | A | 451 | $103.36 | $46,615 | 451 Direct | — | Acquired | -9.5% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | CVS | Deferred Stock Units | Common Stock (1,448) | $0.00 | — | 1,448 | Acquired |
| Nov. 20, 2025 | CVS | Deferred Stock Units | Common Stock (1,652) | $0.00 | — | 1,652 | Acquired |
| May 15, 2025 | CVS | Deferred Stock Units | Common Stock (2,077) | $0.00 | — | 2,077 | Acquired |
| Nov. 21, 2024 | CVS | Deferred Stock Units | Common Stock (2,200) | $0.00 | — | 2,200 | Acquired |
| May 16, 2024 | CVS | Share Credits | Common Stock (2,184) | $0.00 | — | 2,184 | Acquired |
| Nov. 15, 2023 | CVS | Share Credits | Common Stock (1,817) | $0.00 | — | 1,817 | Acquired |
| May 18, 2023 | CVS | Share Credits | Common Stock (1,329) | $0.00 | — | 1,329 | Acquired |
| Nov. 17, 2022 | CVS | Share Credits | Common Stock (1,323) | $0.00 | — | 1,323 | Acquired |
| May 11, 2022 | CVS | Share Credits | Common Stock (1,282) | $0.00 | — | 1,282 | Acquired |
| Nov. 17, 2021 | CVS | Share Credits | Common Stock (1,254) | $0.00 | — | 1,254 | Acquired |
| May 13, 2021 | CVS | Share Credits | Common Stock (1,379) | $0.00 | — | 1,379 | Acquired |
| Nov. 18, 2020 | CVS | Share Credits | Common Stock (1,752) | $0.00 | — | 1,752 | Acquired |
| May 14, 2020 | CVS | Share Credits | Common Stock (1,866) | $0.00 | — | 1,866 | Acquired |
| Nov. 20, 2019 | CVS | Share Credits | Common Stock (1,552) | $0.00 | — | 1,552 | Acquired |
| May 16, 2019 | CVS | Share Credits | Common Stock (2,223) | $0.00 | — | 2,223 | Acquired |
| Nov. 8, 2017 | CVS | Share Credits | Common Stock (2,029) | $0.00 | — | 2,029 | Acquired |
| May 10, 2017 | CVS | Share Credits | Common Stock (1,730) | $0.00 | — | 1,730 | Acquired |
| Nov. 2, 2016 | CVS | Share Credits | Common Stock (1,668) | $0.00 | — | 1,668 | Acquired |
| May 19, 2016 | CVS | Share Credits | Common Stock (1,387) | $0.00 | — | 1,387 | Acquired |
| Nov. 4, 2015 | CVS | Share Credits | Common Stock (1,406) | $0.00 | — | 1,406 | Acquired |
| May 7, 2015 | CVS | Share Credits | Common Stock (1,409) | $0.00 | — | 1,409 | Acquired |
| March 5, 2015 | CVS | Share Credits | Common Stock (451) | $0.00 | — | 451 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).